p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914940 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jeanne Rakotopare und 1 weiteren Autor:innen. Beteiligte Einrichtung: Genetics of Tumor Suppression, Institut Curie, CEDEX 05, 75248 Paris, France. Hauptthemen laut MEDLINE: Fanconi Anemia, Anemia, Diamond-Blackfan, Dyskeratosis Congenita. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation ARC pour la Recherche sur le Cancer, Fondation ARC.
Abstract (Originalsprache)
Mice with a constitutive increase in p53 activity exhibited features of dyskeratosis congenita (DC), a bone marrow failure syndrome (BMFS) caused by defective telomere maintenance. Further studies confirmed, in humans and mice, that germline mutations affecting TP53 or its regulator MDM4 may cause short telomeres and alter hematopoiesis, but also revealed features of Diamond–Blackfan anemia (DBA) or Fanconi anemia (FA), two BMFSs, respectively, caused by defects in ribosomal function or DNA repair. p53 downregulates several genes mutated in DC, either by binding to promoter sequences (DKC1) or indirectly via the DREAM repressor complex (RTEL1, DCLRE1B), and the p53-DREAM pathway represses 22 additional telomere-related genes. Interestingly, mutations in any DC-causal gene will cause telomere dysfunction and subsequent p53 activation to further promote the repression of p53-DREAM targets. Similarly, ribosomal dysfunction and DNA lesions cause p53 activation, and p53-DREAM targets include the DBA-causal gene TSR2, at least 9 FA-causal genes, and 38 other genes affecting ribosomes or the FA pathway. Furthermore, patients with BMFSs may exhibit brain abnormalities, and p53-DREAM represses 16 genes mutated in microcephaly or cerebellar hypoplasia. In sum, positive feedback loops and the repertoire of p53-DREAM targets likely contribute to partial phenotypic overlaps between BMFSs of distinct molecular origins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics of Tumor Suppression, Institut Curie, CEDEX 05, 75248 Paris, France.
- CNRS UMR3244, 75005 Paris, France.
- Faculty of Science and Engineering, Sorbonne University, 75005 Paris, France.
- Institut Curie, PSL Research University, 75005 Paris, France.
ORCID-Profile: Jeanne Rakotopare, Franck Toledo
Förderung
- Fondation ARC pour la Recherche sur le Cancer
- Fondation ARC
Zitieren
APA
Rakotopare, J., & Toledo, F. (2023). p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914940
Vancouver
Rakotopare J, Toledo F. p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914940
BibTeX
@article{Rakotopare2023,
author = {Rakotopare, Jeanne and Toledo, Franck},
title = {p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914940}
}
EUVIMED